With a market cap of $29.9 billion, San Diego, California-based ResMed Inc. (RMD) is a global health technology company dedicated to improving lives through innovative, AI-powered digital health solutions, cloud-connected devices, and intelligent software. Operating in over 140 countries, Resmed is transforming home healthcare by making it more personalized, accessible, and effective, with a vision of helping people achieve better sleep, breathing, and overall health.
The San Diego, California-based company is slated to announce its fiscal Q4 2026 results soon. Ahead of the event, analysts expect RMD to report an adjusted EPS of $2.90, up 13.7% from $2.55 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in each of the past four quarterly reports.